Cited by 903Cardiovascular Function and Risk FactorsCardiac Fibrosis and RemodelingCardiomyopathy and Myosin Studies

The DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.

Molecular mechanisms of diabetic cardiomyopathy

Open access

Bugger, Heiko, Abel, E. Dale·2014·Diabetologia

DOI 10.1007/s00125-014-3171-6PMC PMC3969857

Open this paper in CoChat — free account Open PDF

Abstract

In recent years, diabetes mellitus has become an epidemic and now represents one of the most prevalent disorders. Cardiovascular complications are the major cause of mortality and morbidity in diabetic patients. While ischaemic events dominate the cardiac complications of diabetes, it is widely recognised that the risk for developing heart failure is also increased in the absence of overt myocardial ischaemia and hypertension or is accelerated in the presence of these comorbidities. These diabetes-associated changes in myocardial structure and function have been called diabetic cardiomyopathy. Numerous molecular mechanisms have been proposed to contribute to the development of diabetic cardiomyopathy following analysis of various animal models of type 1 or type 2 diabetes and in genetically modified mouse models. The steady increase in reports presenting novel mechanistic data on this subject expands the list of potential underlying mechanisms. The current review provides an update on molecular alterations that may contribute to the structural and functional alterations in the diabetic heart.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00125-014-3171-6

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

MicroRNA miR-133 Represses HERG K+ Channel Expression Contributing to QT Prolongation in Diabetic Hearts
Xiao, J., Luo, X., Lin, H., Zhang, Y., Lu, Y., Wang, N., Zhang, Y., Yang, B., & Wang, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700015200 · Cited by 233
Retracted
Retracted: Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up‐regulation contribute to the onset of diabetic cardiomyopathy
Ma, H., Li, S., Xu, P., Babcock, S. A., Dolence, E. K., Brownlee, M., Li, J., & Ren, J. T. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00547.x · Cited by 154
Retracted
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
The Framingham Study
Dawber, T. R. (1980) · Harvard University Press eBooks · doi:10.4159/harvard.9780674492097 · Cited by 1,965
Identification of hundreds of conserved and nonconserved human microRNAs
Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E., et al. (2005) · Nature Genetics · doi:10.1038/ng1590 · Cited by 1,841
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,835
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., Asahi, M., et al. (2007) · Nature Medicine · doi:10.1038/nm1574 · Cited by 1,520

Show all 153 references

Sorted by citations

Items 401–500 of 903

Energy metabolism in cardiovascular diseases: unlocking the hidden powerhouse of cardiac pathophysiology
Chen, L., Chen, M., Yang, X., Hu, Y., Qiu, C., Fu, Y., Lan, X., Luo, G., Liu, Q., & Liu, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1617305 · Cited by 24
Characterization of Cognitive Impairment in Type 2 Diabetic Rats
Mehta, B. K., & Banerjee, S. (2017) · Indian Journal of Pharmaceutical Sciences · doi:10.4172/pharmaceutical-sciences.1000292 · Cited by 21
Mechanism of N-acetylcysteine in alleviating diabetic myocardial ischemia reperfusion injury by regulating PTEN/Akt pathway through promoting DJ-1
Li, W., Li, W., Leng, Y., Xiong, Y., Xue, R., Chen, R., & Xia, Z. (2020) · Bioscience Reports · doi:10.1042/bsr20192118 · Cited by 21
SGLT1 Knockdown Attenuates Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis
Lin, H., Guan, L., Meng, L., Uzui, H., & Guo, H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.700366 · Cited by 22
Proteomic Analysis Suggests Altered Mitochondrial Metabolic Profile Associated With Diabetic Cardiomyopathy
Gomes, K. P., Jadli, A. S., de Almeida, L. G. N., Ballasy, N., Edalat, P., Shandilya, R., Young, D. W., Belke, D. D., Shearer, J., Dufour, A., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.791700 · Cited by 22
Fatty acid metabolism disorders and potential therapeutic traditional Chinese medicines in cardiovascular diseases
Liu, X., Xu, X., Zhang, T., Xu, L., Tao, H., Liu, Y., Zhang, Y. C., & Meng, X. (2023) · Phytotherapy Research · doi:10.1002/ptr.7965 · Cited by 22
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
Remodeling of substrate consumption in the murine sTAC model of heart failure
Turer, A. T., Altamirano, F. J., Schiattarella, G. G., May, H. I., Gillette, T. G., Malloy, C. R., & Merritt, M. E. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.07.007 · Cited by 21
Long Non-coding RNA: A Key Regulator in the Pathogenesis of Diabetic Cardiomyopathy
Guo, Y., Feng, X., Wang, D., Kang, X., Zhang, L., Ren, H., & Yuan, G. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.655598 · Cited by 21
P2X7 Receptor Deficiency Ameliorates STZ-Induced Cardiac Damage and Remodeling Through PKCβ and ERK
Huang, S., Wang, W., Li, L., Wang, T., Zhao, Y., Lin, Y., Huang, W., Wang, Y., & Huang, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.2139/ssrn.3812380 · Cited by 21
Puerarin Suppresses Na+-K+-ATPase–Mediated Systemic Inflammation and CD36 Expression, and Alleviates Cardiac Lipotoxicity In Vitro and In Vivo
Qin, H., Zhang, Y., Wang, R., Du, X., Li, L., & Du, H. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000431 · Cited by 21
The impact of case management on reducing readmission for patients diagnosed with heart failure and diabetes
McCants, K. M., Reid, K. B., Williams, I., Miller, D. E., Rubin, R., & Dutton, S. (2019) · Professional Case Management · doi:10.1097/ncm.0000000000000359 · Cited by 59
piR112710 attenuates diabetic cardiomyopathy through inhibiting Txnip/NLRP3-mediated pyroptosis in db/db mice
Jiao, A., Liu, H., Wang, H. H., Yu, J., Gong, L., Zhang, H., & Fu, L. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111333 · Cited by 20
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy
Tate, M., Perera, N., Prakoso, D., Willis, A. M., Deo, M., Oseghale, O., Qian, H., Donner, D. G., Kiriazis, H., Blasio, M. J. D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.719290 · Cited by 21
Assessment of subclinical left ventricle myocardial dysfunction using global myocardial work in type 2 diabetes mellitus patients with preserved left ventricle ejection fraction
Wang, T., Li, L., Huang, J., & Li, F. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00781-x · Cited by 20
Triad3A-Mediated K48-Linked ubiquitination and degradation of TLR9 impairs mitochondrial bioenergetics and exacerbates diabetic cardiomyopathy
Kong, C., Guo, Z., Liu, F.-Y., Tang, N., Wang, M., Yang, D., Li, C., Yang, Z., Ma, Y., Wang, P., et al. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.08.015 · Cited by 20
Potential pathogenic roles of ferroptosis and cuproptosis in cadmium-induced or exacerbated cardiovascular complications in individuals with diabetes
Saedi, S., Tan, Y., Watson, S. E., Wintergerst, K. A., & Cai, L. F. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1461171 · Cited by 25
The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Restores Cardiomyocyte Contractility in a Rat Model of Early Diabetes
Bocchi, L., Motta, B. M., Savi, M., Vilella, R., Meraviglia, V., Rizzi, F., Galati, S., Buschini, A., Lazzaretti, M., Pramstaller, P. P., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081873 · Cited by 19
Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?
Khan, S. M., & Kamal, M. A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190708173108 · Cited by 20
The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart
Tate, M., Higgins, G. C., Blasio, M. J. D., Lindblom, R. S. J., Prakoso, D., Deo, M., Kiriazis, H., Park, M. S., Baeza-Garza, C. D., Caldwell, S. T., et al. (2019) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-019-06914-9 · Cited by 20
Enhanced Catecholamine Flux and Impaired Carbonyl Metabolism Disrupt Cardiac Mitochondrial Oxidative Phosphorylation in Diabetes Patients
Nelson, M.-A. M., Efird, J. T., Kew, K. A., Katunga, L. A., Monroe, T. B., Doorn, J. A., Beatty, C., Shi, Q., Akhter, S. A., Alwair, H., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8122 · Cited by 23
Age and Sex Influence Mitochondria and Cardiac Health in Offspring Exposed to Maternal Glucolipotoxicity
Louwagie, E. J., Larsen, T. D., Wachal, A. L., Gandy, T. C. T., Eclov, J. A., Rideout, T. C., Kern, K. A., Cain, J. T., Anderson, R. H., Mdaki, K. S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101746 · Cited by 20
Heart failure subtypes: Pathophysiology and definitions
Swedberg, K. B. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108815 · Cited by 22
Dietary fatty acid metabolism in prediabetes
Noll, C., & Carpentier, A. C. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000369 · Cited by 20
Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door
Palazzuoli, A., Ruocco, G. M., & Gronda, E. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09972-6 · Cited by 20
Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
Wang, Y., Yu, K., Zhao, C., Zhou, L., Cheng, J. R., Wang, D. W., & Zhao, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.683335 · Cited by 19
Cardiac Structure and Function and Diabetes‐Related Risk of Death or Heart Failure in Older Adults
Inciardi, R. M., Claggett, B. L., Gupta, D. K., Cheng, S. C., Liu, J., Tcheugui, J. B. E., Ndumele, C. E., Matsushita, K., Selvin, E., Solomon, S. D., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022308 · Cited by 22
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases
Kushner, P. R., Cavender, M. A., & Mende, C. W. (2022) · Clinical Diabetes · doi:10.2337/cd21-0119 · Cited by 26
Islet amyloid toxicity: From genesis to counteracting mechanisms
Marmentini, C., Branco, R. C. S., Boschero, A. C., & Kurauti, M. A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30600 · Cited by 19
The Importance of SGLT-2 Inhibitors as Both the Prevention and the Treatment of Diabetic Cardiomyopathy
Kowalska, K., Wilczopolski, P., Buławska, D., Młynarska, E., Rysz, J., & Franczyk, B. (2022) · Antioxidants · doi:10.3390/antiox11122500 · Cited by 20
Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases
Li, R., & Huang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021666 · Cited by 19
Association of the triglyceride‐glucose index with subclinical left ventricular dysfunction in type 2 diabetes mellitus patients: A retrospective cross‐sectional study
Sun, Q., Liu, J., Meng, R., Zhang, N., Yao, J., Yang, F., & Zhu, D. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14026 · Cited by 19
Seven-Day Caloric and Saturated Fat Restriction Increases Myocardial Dietary Fatty Acid Partitioning in Impaired Glucose-Tolerant Subjects
Noll, C., Kunach, M., Frisch, F., Bouffard, L., Dubreuil, S., Jean-Denis, F., Phoenix, S., Cunnane, S. C., Guérin, B., Turcotte, É. E., et al. (2015) · Diabetes · doi:10.2337/db15-0337 · Cited by 21
PI3Ks in Diabetic Cardiomyopathy
Li, M., Murabito, A., Ghigo, A., & Hirsch, E. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000511 · Cited by 19
The clock gene, brain and muscle Arnt-like 1, regulates autophagy in high glucose-induced cardiomyocyte injury
Qiao, L., Guo, B., Zhang, H. E., Yang, R., Chang, L., Wang, Y., Jin, X., Liu, S., & Li, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.20811 · Cited by 19
Restoration of myocardial glucose uptake with facilitated myocardial glucose transporter 4 translocation contributes to alleviation of diabetic cardiomyopathy in rats after duodenal‐jejunal bypass
Huang, X., Wu, D., Cheng, Y., Zhang, X., Liu, T., Liu, Q., Xia, P., Zhang, G., Hu, S., & Liu, S. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12948 · Cited by 17
Current advances in the study of diabetic cardiomyopathy: From clinicopathological features to molecular therapeutics (Review)
Sun, L., Yu, M., Zhou, T., Zhang, S., He, G., Wang, G., & Gang, X. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10473 · Cited by 19
miR‐34a attenuates myocardial fibrosis in diabetic cardiomyopathy mice via targeting Pin‐1
Zhang, X., Zhang, G., & Bai, Z. (2020) · Cell Biology International · doi:10.1002/cbin.11512 · Cited by 20
Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol
Savi, M., Bocchi, L., Sala, R., Frati, C., Lagrasta, C. A. M., Madeddu, D., Falco, A., Pollino, S., Bresciani, L., Miragoli, M., et al. (2016) · Nutrients · doi:10.3390/nu8110729 · Cited by 18
Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats
Chang, G., Yeh, Y., Chen, W.-J., Ko, Y., Pang, J. S., & Lee, H.-Y. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.252080 · Cited by 19
MicroRNA-142-3p inhibits high-glucose-induced endothelial-to-mesenchymal transition through targeting TGF-β1/Smad pathway in primary human aortic endothelial cells.
Zhu, G., Li, R., Zeng, Y., Zhou, T., Xiong, F., & Zhu, M. (2018) · PubMed Central · Cited by 19
Impaired SERCA2a phosphorylation causes diabetic cardiomyopathy through impinging on cardiac contractility and precursor protein processing
Quan, C., Zhu, S., Wang, R., Chen, J., Chen, Q., Li, M., Su, S., Du, Q., Liu, M., Wang, H., et al. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac013 · Cited by 18
Echocardiographic Changes in Newly Diagnosed Type 2 Diabetes Mellitus Patients with and without Hypertension
Zhao, Z., Hou, C., Ye, X., & Cheng, J. (2020) · Medical Science Monitor · doi:10.12659/msm.918972 · Cited by 20
Exploring the Role of Hsp60 in Alzheimer’s Disease and Type 2 Diabetes: Suggestion for Common Drug Targeting
Zimbone, S., Rosa, M. C. D., Chiechio, S., & Giuffrida, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512456 · Cited by 18
Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF
Fu, Q., Zhou, L., Fan, Y., Liu, F., Fan, Y., Zhang, X., Li, W., & Cheng, L. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03591-3 · Cited by 21
Implication of Pattern-Recognition Receptors in Cardiovascular Diseases
Wang, X., & Yi, F. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6184 · Cited by 18
Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes
Stewart, B. D., Scott, C. E., McCoy, T. P., Yin, G., Despa, F., Despa, S. I., & Kekenes-Huskey, P. M. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.11.006 · Cited by 18
In-Depth Insight Into the Mechanisms of Cardiac Dysfunction in Patients With Type 1 Diabetes Mellitus Using Layer-Specific Strain Analysis
Iso, T., Takahashi, K., Yazaki, K., Ifuku, M., Nii, M., Fukae, T., Yazawa, R., Ishikawa, A., Haruna, H., Takubo, N., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-18-1245 · Cited by 20
Reduced fatty acid uptake aggravates cardiac contractile dysfunction in streptozotocin-induced diabetic cardiomyopathy
Umbarawan, Y., Kawakami, R., Syamsunarno, M. R. A. A., Koitabashi, N., Obinata, H., Yamaguchi, A., Hanaoka, H., Hishiki, T., Hayakawa, N., Sunaga, H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77895-1 · Cited by 18
Changes in Cardiac Metabolism in Prediabetes
de Wit‐Verheggen, V. H. W., & van de Weijer, T. (2021) · Biomolecules · doi:10.3390/biom11111680 · Cited by 17
Diabetes, heart damage, and angiotensin II. What is the relationship link between them? A minireview
Pedreáñez, A. B., Mosquera, J., Muñóz, N., Robalino, J., & Tene, D. M. (2022) · Endocrine Regulations · doi:10.2478/enr-2022-0007 · Cited by 19
Irisin alleviates high glucose-induced hypertrophy in H9c2 cardiomyoblasts by inhibiting endoplasmic reticulum stress
Li, X., Zhang, D.-Q., Wang, X., Zhang, Q., Liu, Q., Song, R., Zhao, X., & Li, X. (2022) · Peptides · doi:10.1016/j.peptides.2022.170774 · Cited by 17
Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals
Wang, Y., Cai, F., Li, G., & Tao, Y. (2022) · Bioengineered · doi:10.1080/21655979.2022.2051859 · Cited by 17
The Beneficial Effects of Chinese Herbal Monomers on Ameliorating Diabetic Cardiomyopathy via Nrf2 Signaling
Gao, Y., Liu, W., Su, X., Li, X., Yu, F., & Zhang, N. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3959390 · Cited by 17
Septic cardiomyopathy: characteristics, evaluation, and mechanism
Xue, W., Pang, J., Liu, J., Wang, H., Guo, H., & Chen, Y. (2022) · Emergency and Critical Care Medicine · doi:10.1097/ec9.0000000000000060 · Cited by 17
Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy
Galis, P., Bartosova, L., Farkašová, V., Barteková, M., Ferenczyová, K., & Rajtík, T. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1451100 · Cited by 19
La inhibición de la PI3Kγ protege contra la miocardiopatía diabética en ratones
Maffei, A., Cifelli, G., Carnevale, R., Iacobucci, R., Pallante, F., Fardella, V., Fardella, S., Hirsch, E., Lembo, G., & Carnevale, D. (2016) · Revista Española de Cardiología · doi:10.1016/j.recesp.2016.04.025 · Cited by 17
LncRNAs: Proverbial Genomic “Junk” or Key Epigenetic Regulators During Cardiac Fibrosis in Diabetes?
Biswas, S., Thomas, A. A., & Chakrabarti, S. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00028 · Cited by 17
Current Trends in Biomaterial Utilization for Cardiopulmonary System Regeneration
Fakoya, A. O. J., Otohinoyi, D. A., & Yusuf, J. A. (2018) · Stem Cells International · doi:10.1155/2018/3123961 · Cited by 17
Facilitated Ca 2+ homeostasis and attenuated myocardial autophagy contribute to alleviation of diabetic cardiomyopathy after bariatric surgery
Huang, X., Liu, S., Wu, D., Cheng, Y., Han, H., Wang, K., Zhang, G., & Hu, S. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00274.2018 · Cited by 17
The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy
Bombicz, M., Priksz, D., Gesztelyi, R., Kiss, R., Hollos, N., Varga, B., Németh, J., Tóth, A., Papp, Z., Szilvássy, Z., et al. (2019) · Molecules · doi:10.3390/molecules24030586 · Cited by 17
Mortality and Morbidity in HFrEF, HFmrEF, and HFpEF Patients with Diabetes in the Middle East
Al‐Jarallah, M., Rajan, R., Al-Zakwani, I. S., Dashti, R., Bulbanat, B., Ridha, M., Sulaiman, K., Alsheikh-Ali, A. A. A., Panduranga, P., AlHabib, K. F., et al. (2020) · Oman Medical Journal · doi:10.5001/omj.2020.17 · Cited by 17
Tom70 protects against diabetic cardiomyopathy through its antioxidant and antiapoptotic properties
Wang, P., Wang, D., Yang, Y., Hou, J., Wan, J., Ran, F., Dai, X., Zhou, P., & Yang, Y. (2020) · Hypertension Research · doi:10.1038/s41440-020-0518-x · Cited by 17
In vivotargeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice
Towner, R. A., Smith, N., Saunders, D., Carrizales, J., Lupu, F., Silasi‐Mansat, R., Ehrenshaft, M., & Mason, R. P. (2015) · Free Radical Research · doi:10.3109/10715762.2015.1050587 · Cited by 17
Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-β dependent manner.
Liu, Y., & Zhang, J. (2015) · PubMed Central · Cited by 17
Cardioprotective effects of the novel curcumin analogue C66 in diabetic mice is dependent on JNK 2 inactivation
Li, C., Miao, X., Lou, Y., Lu, Z., Adhikari, B. K., Wang, Y., Liu, Q., Sun, J., & Wang, Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13924 · Cited by 17
Exercise Training Attenuates the Development of Cardiac Autonomic Dysfunction in Diabetic Rats
Nakos, I., Kadoglou, N. P. E., Gkeka, P., Tzallas, A. T., Γιαννακέας, Ν., Tsalikakis, D., Katsimpoulas, M., Mantziaras, G., Kostomitsopoulos, N. G., Liapis, C. D., et al. (2018) · In Vivo · doi:10.21873/invivo.11396 · Cited by 17
A Novel Polysaccharide From Heimioporus retisporus Displays Hypoglycemic Activity in a Diabetic Mouse Model
Feng, X., Wang, P., Lu, Y., Zhang, Z., ChunXin, Y., Tian, G., & Liu, Q. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.964948 · Cited by 16
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation
Vilella, R., Izzo, S., Naponelli, V., Savi, M., Bocchi, L., Dallabona, C., Gerra, M. C., Stilli, D., & Bettuzzi, S. (2022) · Pharmaceuticals · doi:10.3390/ph15111337 · Cited by 16
Metformin: Expanding the Scope of Application—Starting Earlier than Yesterday, Canceling Later
Kononova, Y. A., Likhonosov, N. P., & Babenko, A. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042363 · Cited by 17
Metabolic regulation of (−)-epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid on the glucose uptake, lipid accumulation and insulin signalling in cardiac H9c2 cells
García-Díez, E., López‐Oliva, M. E., Pérez‐Jiménez, J., Martín, M. Á., & Ramos, S. (2022) · Food & Function · doi:10.1039/d2fo00182a · Cited by 16
Loss of the melanocortin-4 receptor in mice causes dilated cardiomyopathy
Litt, M. J., Okoye, G. D., Lark, D. S., Çakır, I., Moore, C. S., Barber, M., Atkinson, J. B., Fessel, J. P., Moslehi, J. J., & Cone, R. D. (2017) · eLife · doi:10.7554/elife.28118 · Cited by 16
Incidence of heart failure in patients with type 1 diabetes: a systematic review of observational studies
Avogaro, A., Azzolina, D., Fadini, G. P., & Baldi, I. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01368-5 · Cited by 16
Ubiquitin-specific protease: an emerging key player in cardiomyopathy
Li, D., & Ma, Q. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02123-0 · Cited by 17
Up regulated Tmbim1 activation promotes high fat diet (HFD)-induced cardiomyopathy by enhancement of inflammation and oxidative stress
Gong, F., Gu, J., & Wang, H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.059 · Cited by 15
Morphine induces physiological, structural, and molecular benefits in the diabetic myocardium
Zemljic‐Harpf, A. E., Hoe, L. E. S., Schilling, J. M., Zuniga-Hertz, J. P., Nguyen, A., Vaishnav, Y. J., Belza, G. J., Budiono, B. P., Patel, P. M., Head, B. P., et al. (2021) · The FASEB Journal · doi:10.1096/fj.201903233r · Cited by 15
Study of long non-coding RNA and mitochondrial dysfunction in diabetic rats
Sultan, H. K., Elayat, W. M., AbouGhalia, A. H., Lasheen, N. N., & Moustafa, A. S. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101516 · Cited by 15
Exosomes for diabetes syndrome: ongoing applications and perspective
Zhu, M., Wu, J., & Gao, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00161f · Cited by 16
Garlic ( Allium sativum L. ) in diabetes and its complications: Recent advances in mechanisms of action
Jiang, Y., Yue, R., Liu, G., Liu, J., Peng, B., Yang, M., Zhao, L., & Li, Z. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2153793 · Cited by 21
Improvement of cardiac dysfunction by bilateral surgical renal denervation in animals with diabetes induced by high fructose and high fat diet
Liu, Y., Li, B., Li, M., Yu, Y., Wang, Z., & Chen, S. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.12.012 · Cited by 15
Subcellular microRNAs in diabetic cardiomyopathy
Li, H., Fan, J., Chen, C., & Wang, D. W. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2205 · Cited by 14
Discovery of a potent G-protein-coupled receptor 119 agonist for the treatment of type 2 diabetes
Pola, S., Shah, S. R., Pingali, H., Zaware, P., Thube, B. R., Makadia, P., Patel, H., Bandyopadhyay, D., Rath, A., Giri, S. R., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116071 · Cited by 15
Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An Update
Koniari, I. C., Velissaris, D., Kounis, N. G., Koufou, E., Artopoulou, E., GREGORIO, C. D., Mplani, V., Paraskevas, T., Tsigkas, G., Hung, M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164660 · Cited by 16
Functional components of Chinese rice wine can ameliorate diabetic cardiomyopathy through the modulation of autophagy, apoptosis, gut microbiota, and metabolites
Yang, J., Song, J., Zhou, J., Lin, H., Wu, Z., Liu, N., Xie, W., Guo, H., & Chi, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.940663 · Cited by 15
Gene expression profiling in hearts of diabetic mice uncovers a potential role of estrogen-related receptor γ in diabetic cardiomyopathy
Lasheras, J., Vilà, M., Zamora, M., Riu, E., Pardo, R., Poncelas, M., Cases, I., Ruiz‐Meana, M., Hernández, C., Felíu, J. E., et al. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.004 · Cited by 15
Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose‐induced injury in cardiomyocytes
Zhang, S., Wang, H., Li, L., Chang, X., Ma, H., Zhang, M., Qing, X., Zhang, L., & Zhang, Z. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14527 · Cited by 15
Impact of HbA1c variability on subclinical left ventricular remodeling and dysfunction in patients with type 2 diabetes mellitus
Li, S., Zheng, Z., Tang, X., Zhong, J., Liu, X., Zhao, Y., Chen, L., Zhu, J., Liu, J., & Chen, Y. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.006 · Cited by 14
Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
Prakoso, D., Tate, M., Blasio, M. J. D., & Ritchie, R. H. (2021) · Clinical Science · doi:10.1042/cs20210052 · Cited by 15
Amylin and diabetic cardiomyopathy – amylin-induced sarcolemmal Ca2+ leak is independent of diabetic remodeling of myocardium
Liu, M., Hoskins, A., Verma, N., Bers, D. M., Despa, S. I., & Despa, F. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.10.024 · Cited by 15
Beyond Folding: Expanding the Functional Landscape of Hsp90 Chaperone Machinery in Health and Disease
Singh, M. K., Ranbhise, J. S., Fu, M., Ju, S., Han, S., Yun, H. R., Choe, W., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110279 · Cited by 15
How Perturbated Metabolites in Diabetes Mellitus Affect the Pathogenesis of Hypertension?
Ning, Z., Song, Z., Wang, C., Peng, S., Wan, X., Liu, Z., & Lü, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.705588 · Cited by 15
Regulating Polyamine Metabolism by miRNAs in Diabetic Cardiomyopathy
Kambis, T. N., Tofilau, H. M. N., Gawargi, F. I., Chandra, S., & Mishra, P. K. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01429-w · Cited by 14
NOX1 promotes myocardial fibrosis and cardiac dysfunction via activating the TLR2/NF-κB pathway in diabetic cardiomyopathy
Zhang, D., Li, Y., Wang, W., Lang, X., Zhang, Y., Zhao, Q., Yan, J., & Zhang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.928762 · Cited by 14
Hemoglobin A1c in type 2 diabetes mellitus patients with preserved ejection fraction is an independent predictor of left ventricular myocardial deformation and tissue abnormalities
Li, Z., Han, D., Qi, T., Deng, J., Li, L., Gao, C., Gao, W. D., Chen, H., Zhang, L., & Chen, W. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03082-5 · Cited by 14
Role of melatonin in mitigation of insulin resistance and ensuing diabetic cardiomyopathy
Nath, A., Ghosh, S., & Bandyopadhyay, D. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122993 · Cited by 15
The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study
Li, J., Xu, H., Li, Y., Shi, K., Fang, H., Yan, W., Guo, Y., & Yang, Z. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02435-4 · Cited by 16
Diabetic Cardiomyopathy: An Update on Emerging Pathological Mechanisms
Kakkar, C., Sharma, V., Mannan, A., Gupta, G., Singh, S. K., Kumar, P., Dua, K., Kaur, A., Singh, S., Dhiman, S., et al. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x331870241025094307 · Cited by 14
Synergistic effect of micronutrients and metformin in alleviating diabetic nephropathy and cardiovascular Dysfunctioning in diabetic rat
Deshmukh, A. B., & Manjalkar, P. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00776-5 · Cited by 14
Cathelicidin-WA ameliorates diabetic cardiomyopathy by inhibiting the NLRP3 inflammasome
Peng, M., Liu, Y., Xu, Y., Li, L., Li, Y., & Yang, H. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1981631 · Cited by 14
Omnifarious fruit polyphenols: an omnipotent strategy to prevent and intervene diabetes and related complication?
Chen, Y., Qie, X., Quan, W., Zeng, M., Qin, F., Chen, J., Adhikari, B., & He, Z. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2000932 · Cited by 16

Authors: Bugger, H., & Abel, E. D.
Affiliations: University of Freiburg (DE)
University of Iowa (US)
Corresponding author: Abel, E. Dale
ORCID: Bugger, Heiko
Abel, E. Dale
Venue: Diabetologia
Publisher: Springer Science and Business Media LLC
Published: 2014-01-30
Volume: 57
Issue: 4
Pages: 660-671
ISSN: 0012-186X (ISSN-L)
1432-0428
DOI: 10.1007/s00125-014-3171-6
PMC: PMC3969857
OpenAlex: W2006499762
Cited by: 903
References: 153
Citations by year: 2026: 51 · 2025: 76 · 2024: 75 · 2023: 79 · 2022: 95 · 2021: 103 · 2020: 100 · 2019: 66 · 2018: 84 · 2017: 62 · 2016: 54 · 2015: 43 · 2014: 14
FWCI: 9.29
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Diabetologia (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (R01HL108379, U01HL087947)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092065)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords: diabetic cardiomyopathy, diabetes mellitus, heart failure, myocardial structure and function, type 1 diabetes, type 2 diabetes, animal models of diabetes, genetically engineered mouse models, cardiovascular complications of diabetes
MeSH terms: Animals, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Heart Failure, Humans, Diabetic Cardiomyopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Molecular mechanisms of diabetic cardiomyopathy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks